VRTX · News · 20261105N

Liquidity and Debt Position

VERTEX PHARMACEUTICALS INC / MA · 2026-11-05 · Importance 64 · Surprise 42

Vertex borrowed $4.5 billion to fund part of its recent Crinetics acquisition, leaving it with net debt for the first time in many years. The borrowing increased Vertex’s financing costs and compensation expenses, although the report provided no amounts for either increase. Vertex’s share count continued to decrease through ongoing stock buybacks, while the report characterized the new debt as small relative to the company’s size and earnings.

Key facts